Researchers are testing whether pregnant women tolerate lower iron doses in prenatal vitamins just as well as the standard higher dose. According to Gram Research analysis, a planned trial of 156 pregnant women in Tanzania will compare prenatal vitamins containing 60 mg, 45 mg, and 30 mg of iron to see which dose causes fewer side effects while remaining effective. Results could change global pregnancy vitamin recommendations if lower doses prove equally acceptable and help more women stick with their supplements.
Pregnant women are often prescribed iron supplements to prevent anemia, but these supplements can cause uncomfortable side effects like nausea and constipation that make women stop taking them. Researchers in Tanzania are testing whether lower doses of iron in prenatal vitamins work just as well while causing fewer problems. This study will have 156 pregnant women try three different iron doses over three months to see which one they prefer and which causes the fewest side effects. Understanding the best iron dose could help more pregnant women stick with their vitamins and stay healthy during pregnancy.
Key Statistics
A randomized crossover trial protocol published in BMJ Open in 2026 plans to enroll 156 pregnant women in Tanzania to compare the acceptability of prenatal vitamins containing 60 mg, 45 mg, and 30 mg of iron, with each woman trying all three formulations over a three-month period.
The study uses quadruple-blinding, meaning pregnant women, doctors, outcome assessors, and data analysts will not know which iron dose is in each vitamin formulation, reducing bias in measuring side effects and acceptability.
Researchers will measure adherence by counting leftover pills and will conduct qualitative interviews with study participants to understand women’s personal experiences and preferences with different iron doses in prenatal vitamins.
The Quick Take
- What they studied: Whether pregnant women tolerate lower doses of iron in prenatal vitamins better than the standard higher dose, and whether they prefer and stick with the lower-dose vitamins.
- Who participated: 156 pregnant women in Dar es Salaam, Tanzania, who will each try three different prenatal vitamin formulations containing different amounts of iron over a three-month period.
- Key finding: This is a study protocol describing a planned trial, not yet completed results. The study will compare how well pregnant women accept and tolerate prenatal vitamins with 60 mg, 45 mg, and 30 mg of iron to determine if lower doses are just as acceptable.
- What it means for you: If lower iron doses work well, pregnant women may experience fewer side effects while still getting the iron they need, making it easier to take vitamins consistently throughout pregnancy. Results won’t be available until the study is completed.
The Research Details
This is a research protocol—a detailed plan for a study that hasn’t been completed yet. Researchers designed a special type of trial called a “crossover trial,” where each pregnant woman will try all three different iron doses, one after another, for one month each. This design is smart because it lets researchers compare how the same woman responds to different doses, which reduces confusion from differences between women.
The study uses “quadruple-blinding,” meaning the pregnant women, doctors, people measuring results, and data analysts won’t know which iron dose is in each vitamin bottle. This prevents bias—where knowing the dose might influence how women report side effects or how researchers interpret results.
Researchers will measure how much women like each vitamin using a simple rating scale, track which formulation they prefer, count leftover pills to see if they took all their vitamins, and ask women detailed questions about their experiences. This combination of numbers and personal stories will give a complete picture of which iron dose works best.
The crossover design is powerful because each woman serves as her own comparison. This means researchers can see real differences between doses without worrying that some women naturally tolerate iron better than others. Blinding prevents both women and researchers from unconsciously favoring one dose. By measuring both what women report and what they actually do (pill counts), researchers can see if women say they like a vitamin but don’t actually take it.
This study has strong quality features: it’s registered publicly (ClinicalTrials.gov), approved by multiple ethics committees in Tanzania and the United States, and uses blinding to prevent bias. However, because this is a protocol document, we don’t yet know if the study will recruit all 156 women or if unexpected problems will arise. The study is being conducted in Tanzania specifically, so results may not apply equally to pregnant women in other countries with different diets and health conditions.
What the Results Show
This document is a study protocol, not a results paper, so actual findings are not yet available. The study is planned to measure how acceptable each iron dose is using a rating scale where women indicate their level of agreement with statements about liking and tolerating each vitamin formulation.
Once completed, the study will show whether pregnant women rate the 30 mg iron dose as equally acceptable as the standard 60 mg dose. If lower doses are just as acceptable, this could change recommendations worldwide, since lower iron doses typically cause fewer side effects like nausea, constipation, and stomach upset.
The research will also identify which formulation women prefer and least prefer, and whether women can correctly guess which dose they’re taking. These details matter because if women can tell the doses apart by taste or side effects, it might affect their willingness to take the vitamins.
The study will examine reported side effects in detail—asking women about nausea, constipation, stomach pain, and other problems with each dose. Researchers will also measure adherence by counting leftover pills, which shows whether women actually took their vitamins as prescribed. Additionally, qualitative interviews with some women will explore their personal experiences, preferences, and reasons for liking or disliking each formulation. These interviews may reveal practical concerns that numbers alone can’t capture.
The World Health Organization currently recommends 60 mg of iron for pregnant women in areas where anemia is common. However, some programs are considering switching to 30 mg iron in multiple micronutrient supplements (which include iron plus folic acid and other vitamins). This study directly addresses that question: is 30 mg enough? Previous research suggests that lower iron doses cause fewer side effects, but no rigorous trial has compared acceptability and adherence across three doses in the same women. This study fills that gap.
This is a protocol document, so actual limitations from conducting the study aren’t yet known. However, potential limitations include: the study only includes pregnant women in Tanzania, so results may not apply to other populations; women know they’re in a study, which might change their behavior; and the study measures acceptability on a rating scale, which is subjective. Additionally, the study doesn’t measure whether babies or mothers have better health outcomes with different iron doses—only whether women tolerate and prefer the vitamins.
The Bottom Line
This study hasn’t produced results yet, so no clinical recommendations can be made. Once completed, if the study shows that 30 mg iron is equally acceptable and doesn’t cause more side effects, health programs may recommend switching from 60 mg to 30 mg iron in prenatal vitamins. This could improve how many pregnant women take their vitamins consistently. Pregnant women should continue taking iron supplements as prescribed by their doctor until new evidence changes recommendations.
Pregnant women, especially those experiencing side effects from iron supplements, should care about this research. Healthcare providers, public health programs, and the World Health Organization should pay attention because results could change global pregnancy vitamin recommendations. Women in low-income countries where anemia is common will likely benefit most if lower iron doses prove effective.
The study was registered in 2024 and is currently recruiting participants. Results likely won’t be available for 1-2 years after enrollment completes. Even after results are published, it typically takes 2-5 years for health organizations to update official recommendations based on new evidence.
Frequently Asked Questions
Does lower iron in prenatal vitamins still prevent anemia during pregnancy?
This study will help answer that question. Currently, the WHO recommends 60 mg iron for pregnant women in areas with high anemia rates. The trial will test whether 30 mg iron is equally acceptable and tolerable, but actual health outcomes aren’t measured in this study design.
What side effects does iron in prenatal vitamins cause?
Common iron side effects include nausea, constipation, stomach upset, and dark stools. These problems make some pregnant women stop taking their vitamins. This study will measure whether lower iron doses cause fewer of these side effects while still providing needed iron.
Why do some pregnant women stop taking their prenatal vitamins?
Side effects like nausea and constipation are major reasons women skip doses or stop taking vitamins entirely. If lower iron doses cause fewer side effects without reducing effectiveness, more women might stick with their supplements throughout pregnancy, improving both maternal and baby health.
When will this study be finished and what will it tell us?
The study is currently recruiting participants and results likely won’t be available for 1-2 years. Once complete, it will show whether pregnant women prefer and tolerate lower iron doses equally well, potentially changing global prenatal vitamin recommendations.
Should I take a lower iron dose if I have side effects?
Don’t change your prenatal vitamin dose without talking to your doctor. Iron is essential during pregnancy. Your doctor can help you find a formulation that works for your body, whether that means a different iron dose, taking it with food, or switching brands.
Want to Apply This Research?
- Track daily prenatal vitamin adherence by logging each dose taken and noting any side effects experienced (nausea, constipation, stomach upset, headache) on a 1-10 scale. This personal data helps identify which formulation works best for your body.
- Set a daily reminder for the same time each morning to take your prenatal vitamin. If you experience side effects, note them in the app and discuss with your doctor—don’t stop taking vitamins without guidance, as iron is essential during pregnancy.
- Over 3 months, track which days you took your full dose, which days you skipped or took partial doses, and what side effects you experienced each day. Share this pattern with your healthcare provider to determine if a different iron dose or formulation might work better for you.
This article describes a research protocol for a study that has not yet been completed. No clinical results are available yet. Pregnant women should continue taking iron supplements as prescribed by their healthcare provider. Do not change your prenatal vitamin dose or stop taking supplements without consulting your doctor, as iron is essential for healthy pregnancy. This information is for educational purposes only and should not replace medical advice from a qualified healthcare professional. Individual responses to iron supplements vary, and your doctor can help determine the best formulation for your specific needs.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.